Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 130

1.

Cardiac Sarcoidosis multi-center randomized controlled trial (CHASM CS- RCT).

Birnie D, Beanlands RSB, Nery P, Aaron SD, Culver DA, DeKemp RA, Gula L, Ha A, Healey JS, Inoue Y, Judson MA, Juneau D, Kusano K, Quinn R, Rivard L, Toma M, Varnava A, Wells G, Wickremasinghe M, Kron J.

Am Heart J. 2020 Feb;220:246-252. doi: 10.1016/j.ahj.2019.10.003. Epub 2019 Oct 20.

PMID:
31911261
2.

A new electrocardiographic definition of left bundle branch block (LBBB) in patients after transcatheter aortic valve replacement (TAVR).

Alqarawi W, Sadek MM, Golian M, Hibbert B, Redpath CJ, Nair GM, Nery PB, Davis DR, Klein A, Birnie DH, Green MS.

J Electrocardiol. 2019 Oct 22. pii: S0022-0736(19)30598-9. doi: 10.1016/j.jelectrocard.2019.10.005. [Epub ahead of print]

PMID:
31668635
3.

Effect of Direct Oral Anticoagulants, Warfarin, and Antiplatelet Agents on Risk of Device Pocket Hematoma: Combined Analysis of BRUISE CONTROL 1 and 2.

Essebag V, Healey JS, Joza J, Nery PB, Kalfon E, Leiria TLL, Verma A, Ayala-Paredes F, Coutu B, Sumner GL, Becker G, Philippon F, Eikelboom J, Sandhu RK, Sapp J, Leather R, Yung D, Thibault B, Simpson CS, Ahmad K, Toal S, Sturmer M, Kavanagh K, Crystal E, Wells GA, Krahn AD, Birnie DH.

Circ Arrhythm Electrophysiol. 2019 Oct;12(10):e007545. doi: 10.1161/CIRCEP.119.007545. Epub 2019 Oct 15.

PMID:
31610718
4.

A Strategy of Lead Abandonment in a Large Cohort of Patients With Sprint Fidelis Leads.

Alqarawi W, Coppens J, Aldawood W, Ramirez FD, Redpath CJ, Nair GM, Nery PB, Davis DR, Abu Shama R, Aydin A, Klein A, Golian M, Schaller RD, Green MS, Birnie DH, Sadek MM.

JACC Clin Electrophysiol. 2019 Sep;5(9):1059-1067. doi: 10.1016/j.jacep.2019.07.006. Epub 2019 Aug 28.

PMID:
31537335
5.

Imaging Cardiac Sarcoidosis With FLT-PET Compared With FDG/Perfusion-PET: A Prospective Pilot Study.

Martineau P, Pelletier-Galarneau M, Juneau D, Leung E, Nery PB, de Kemp R, Beanlands R, Birnie D.

JACC Cardiovasc Imaging. 2019 Nov;12(11 Pt 1):2280-2281. doi: 10.1016/j.jcmg.2019.06.020. Epub 2019 Aug 14. No abstract available.

PMID:
31422126
6.

Letter by Birnie et al Regarding Article, "Diagnostic Accuracy of Advanced Imaging in Cardiac Sarcoidosis: Implications for the Diagnosis of Isolated Cardiac Sarcoidosis".

Birnie DH, Nery PB, Beanlands R.

Circ Cardiovasc Imaging. 2019 Aug;12(8):e009614. doi: 10.1161/CIRCIMAGING.119.009614. Epub 2019 Aug 15. No abstract available.

PMID:
31412720
7.

Left atrial vortex size and velocity distributions by 4D flow MRI in patients with paroxysmal atrial fibrillation: Associations with age and CHA2 DS2 -VASc risk score.

Garcia J, Sheitt H, Bristow MS, Lydell C, Howarth AG, Heydari B, Prato FS, Drangova M, Thornhill RE, Nery P, Wilton SB, Skanes A, White JA.

J Magn Reson Imaging. 2020 Mar;51(3):871-884. doi: 10.1002/jmri.26876. Epub 2019 Jul 23.

PMID:
31334898
8.

Left atrial imaging and registration of fibrosis with conduction voltages using LGE-MRI and electroanatomical mapping.

Lee J, Thornhill RE, Nery P, Robert deKemp, Peña E, Birnie D, Adler A, Ukwatta E.

Comput Biol Med. 2019 Aug;111:103341. doi: 10.1016/j.compbiomed.2019.103341. Epub 2019 Jun 25.

PMID:
31279164
9.

Spontaneous coronary artery dissection in cardiac sarcoidosis.

Kandolin R, Ekström K, Simard T, Hibbert B, Nery P, Lehtonen J, Kupari M, Birnie D.

Oxf Med Case Reports. 2019 May 31;2019(5):omz033. doi: 10.1093/omcr/omz033. eCollection 2019 May.

10.

Health Economic Analysis of Catheter Ablation for Ventricular Tachycardia: Breaking Even With Medical Therapy?

Nery PB, Sadek MM, Nair GM.

Can J Cardiol. 2019 Feb;35(2):147-149. doi: 10.1016/j.cjca.2018.12.012. Epub 2018 Dec 12. No abstract available.

PMID:
30760419
11.

Evaluation of a novel cardioversion intervention for atrial fibrillation: the Ottawa AF cardioversion protocol.

Ramirez FD, Sadek MM, Boileau I, Cleland M, Nery PB, Nair GM, Redpath CJ, Green MS, Davis DR, Charron K, Henne J, Zakutney T, Beanlands RSB, Hibbert B, Wells GA, Birnie DH.

Europace. 2019 May 1;21(5):708-715. doi: 10.1093/europace/euy285.

PMID:
30535367
12.

Continued vs. interrupted direct oral anticoagulants at the time of device surgery, in patients with moderate to high risk of arterial thrombo-embolic events (BRUISE CONTROL-2).

Birnie DH, Healey JS, Wells GA, Ayala-Paredes F, Coutu B, Sumner GL, Becker G, Verma A, Philippon F, Kalfon E, Eikelboom J, Sandhu RK, Nery PB, Lellouche N, Connolly SJ, Sapp J, Essebag V.

Eur Heart J. 2018 Nov 21;39(44):3973-3979. doi: 10.1093/eurheartj/ehy413.

PMID:
30462279
13.

Completely nonfluoroscopic catheter ablation of left atrial arrhythmias and ventricular tachycardia.

Sadek MM, Ramirez FD, Nery PB, Golian M, Redpath CJ, Nair GM, Birnie DH.

J Cardiovasc Electrophysiol. 2019 Jan;30(1):78-88. doi: 10.1111/jce.13735. Epub 2018 Oct 22.

PMID:
30203499
14.

Characterization of Low-Voltage Areas in Patients With Atrial Fibrillation: Insights From High-Density Intracardiac Mapping.

Nery PB, Al Dawood W, Nair GM, Redpath CJ, Sadek MM, Chen L, Green MS, Wells G, Birnie DH.

Can J Cardiol. 2018 Aug;34(8):1033-1040. doi: 10.1016/j.cjca.2018.04.008. Epub 2018 Apr 12.

PMID:
30056843
15.

Prognostic Value of Noninducibility on Outcomes of Ventricular Tachycardia Ablation: A VANISH Substudy.

Essebag V, Joza J, Nery PB, Doucette S, Nault I, Rivard L, Gula L, Deyell M, Raymond JM, Lane C, Sapp JL.

JACC Clin Electrophysiol. 2018 Jul;4(7):911-919. doi: 10.1016/j.jacep.2018.03.013. Epub 2018 May 30.

16.

Prevalence of left atrial appendage thrombus detected by transoesophageal echocardiography before catheter ablation of atrial fibrillation in patients anticoagulated with non-vitamin K antagonist oral anticoagulants.

Alqarawi W, Birnie DH, Spence S, Ramirez FD, Redpath CJ, Lemery R, Nair GM, Nery PB, Davis DR, Green MS, Beauchesne L, Chan K, Ascah K, Burwash I, Sadek MM.

Europace. 2019 Jan 1;21(1):48-53. doi: 10.1093/europace/euy129.

PMID:
29897439
17.

Bi-atrial fibrosis detected using three-dimensional late gadolinium enhancement magnetic resonance imaging in a patient with cardiac sarcoidosis.

Spence S, Pena E, Thornhill RE, Nery PB, Birnie DH.

Oxf Med Case Reports. 2018 May 16;2018(5):omy016. doi: 10.1093/omcr/omy016. eCollection 2018 May.

18.

Canadian Registry of Implantable Electronic Device Outcomes: Surveillance of High-Voltage Leads.

Parkash R, Thibault B, Philippon F, Yee R, Stephenson E, Healey J, Krahn A, Exner D, Simpson C, Crystal E, Nery P, Essebag V, Sterns L, Tang A, Wells G.

Can J Cardiol. 2018 Jun;34(6):808-811. doi: 10.1016/j.cjca.2018.02.009. Epub 2018 Feb 19.

PMID:
29801745
19.

Swallowing-induced atrial tachycardia.

Mathew R, Green MS, Nery PB.

CMAJ. 2018 Apr 23;190(16):E507-E509. doi: 10.1503/cmaj.171261. No abstract available.

20.

Differentiating Ventricular From Supraventricular Arrhythmias Using the Postpacing Interval After Failed Antitachycardia Pacing.

Bennett MT, Leader N, Sapp J, Parkash R, Gardner M, Healey JS, Thibault B, Sterns L, Essebag V, Birnie D, Sivakumaran S, Nery P, Andrade JG, Krahn AD, Tang A.

Circ Arrhythm Electrophysiol. 2018 Apr;11(4):e005921. doi: 10.1161/CIRCEP.117.005921.

PMID:
29618476
21.

Bidirectional ventricular tachycardia in ischemic cardiomyopathy during ablation.

Yeo C, Green MS, Nair GM, Birnie DH, Nery PB, Sadek MM.

HeartRhythm Case Rep. 2017 Sep 5;3(11):527-530. doi: 10.1016/j.hrcr.2017.08.005. eCollection 2017 Nov. No abstract available.

22.

Mexiletine or catheter ablation after amiodarone failure in the VANISH trial.

Deyell MW, Steinberg C, Doucette S, Parkash R, Nault I, Gray C, Essebag V, Gardner M, Sterns LD, Healey JS, Hruczkowski T, Rivard L, Leong-Sit P, Nery PB, Sapp JL.

J Cardiovasc Electrophysiol. 2018 Apr;29(4):603-608. doi: 10.1111/jce.13431. Epub 2018 Feb 1.

PMID:
29356207
23.

Quality of life with ablation or medical therapy for ventricular arrhythmias: A substudy of VANISH.

Gula LJ, Doucette S, Leong-Sit P, Tang ASL, Parkash R, Sarrazin JF, Thibault B, Essebag V, Tung SK, Deyell MW, Raymond JM, Lane C, Nery PB, Veenhuyzen GD, Redfearn DP, Healey JS, Roux JF, Giddens K, Sapp JL.

J Cardiovasc Electrophysiol. 2018 Mar;29(3):421-434. doi: 10.1111/jce.13419. Epub 2018 Jan 30.

PMID:
29316012
24.

Safety and long-term effectiveness of paroxysmal atrial fibrillation ablation with a contact force-sensing catheter: real-world experience from a prospective, multicentre observational cohort registry.

De Potter T, Van Herendael H, Balasubramaniam R, Wright M, Agarwal SC, Sanders P, Khaykin Y, Latcu DG, Maury P, Pani A, Hayes J, Kalman J, Nery P, Duncan E.

Europace. 2018 Nov 1;20(FI_3):f410-f418. doi: 10.1093/europace/eux290.

PMID:
29315382
25.

How common is isolated cardiac sarcoidosis? Extra-cardiac and cardiac findings on clinical examination and whole-body 18F-fluorodeoxyglucose positron emission tomography.

Juneau D, Nery P, Russo J, de Kemp RA, Leung E, Beanlands RSB, Birnie DH.

Int J Cardiol. 2018 Feb 15;253:189-193. doi: 10.1016/j.ijcard.2017.09.204.

PMID:
29306462
26.

Effect of Baseline Antiarrhythmic Drug on Outcomes With Ablation in Ischemic Ventricular Tachycardia: A VANISH Substudy (Ventricular Tachycardia Ablation Versus Escalated Antiarrhythmic Drug Therapy in Ischemic Heart Disease).

Parkash R, Nault I, Rivard L, Gula L, Essebag V, Nery P, Tung S, Raymond JM, Sterns L, Doucette S, Wells G, Tang ASL, Stevenson WG, Sapp JL.

Circ Arrhythm Electrophysiol. 2018 Jan;11(1):e005663. doi: 10.1161/CIRCEP.117.005663.

PMID:
29305400
27.

Canadian Registry of Implantable Electronic Device Outcomes: Longer-term follow-up of the Riata lead under advisory.

Parkash R, Thibault B, Philippon F, Mangat I, Coutu B, Bennett M, Crystal E, Healey J, Verma A, Sandhu R, Cameron D, Ayala-Paredes F, Sterns L, Essebag V, Sturmer M, Nery P, Wells G, Krahn A.

Heart Rhythm. 2018 Apr;15(4):524-529. doi: 10.1016/j.hrthm.2017.11.033. Epub 2017 Dec 2.

PMID:
29198903
28.

Efficacy and safety of driver-guided catheter ablation for atrial fibrillation: A systematic review and meta-analysis.

Ramirez FD, Birnie DH, Nair GM, Szczotka A, Redpath CJ, Sadek MM, Nery PB.

J Cardiovasc Electrophysiol. 2017 Dec;28(12):1371-1378. doi: 10.1111/jce.13313. Epub 2017 Sep 5. Review.

PMID:
28800192
29.

Management of Implantable Cardioverter Defibrillator Recipients: Care Beyond Guidelines.

Philippon F, Sterns LD, Nery PB, Parkash R, Birnie D, Rinne C, Mondesert B, Exner D, Bennett M.

Can J Cardiol. 2017 Aug;33(8):977-990. doi: 10.1016/j.cjca.2017.05.012. Epub 2017 May 26. Review.

PMID:
28754398
30.

Three-year outcomes and reconnection patterns after initial contact force guided pulmonary vein isolation for paroxysmal atrial fibrillation.

Nair GM, Yeo C, MacDonald Z, Ainslie MP, Alqarawi WA, Nery PB, Redpath CJ, Sadek M, Spence S, Green MS, Birnie DH.

J Cardiovasc Electrophysiol. 2017 Sep;28(9):984-993. doi: 10.1111/jce.13280. Epub 2017 Sep 1.

PMID:
28635046
31.

Letter by Nery et al Regarding Article, "Implantable Cardioverter-Defibrillator for Nonischemic Cardiomyopathy: An Updated Meta-Analysis".

Nery PB, Lewis KB, Birnie DH.

Circulation. 2017 Jun 20;135(25):e1198-e1199. doi: 10.1161/CIRCULATIONAHA.117.027389. No abstract available.

PMID:
28630274
32.

Cardiac Resynchronization Therapy Reduces Ventricular Arrhythmias in Primary but Not Secondary Prophylactic Implantable Cardioverter Defibrillator Patients: Insight From the Resynchronization in Ambulatory Heart Failure Trial.

Sapp JL, Parkash R, Wells GA, Yetisir E, Gardner MJ, Healey JS, Thibault B, Sterns LD, Birnie D, Nery PB, Sivakumaran S, Essebag V, Dorian P, Tang AS.

Circ Arrhythm Electrophysiol. 2017 Mar;10(3). pii: e004875. doi: 10.1161/CIRCEP.116.004875.

PMID:
28292754
33.

Inter- and Intraobserver Agreement of 18F-FDG PET/CT Image Interpretation in Patients Referred for Assessment of Cardiac Sarcoidosis.

Ohira H, Ardle BM, deKemp RA, Nery P, Juneau D, Renaud JM, Klein R, Clarkin O, MacDonald K, Leung E, Nair G, Beanlands R, Birnie D.

J Nucl Med. 2017 Aug;58(8):1324-1329. doi: 10.2967/jnumed.116.187203. Epub 2017 Mar 2.

34.

Reply: Treatment Nuances in Cardiac Sarcoidosis.

Birnie DH, Nery PB, Ha AC, Beanlands RS.

J Am Coll Cardiol. 2017 Jan 24;69(3):363. doi: 10.1016/j.jacc.2016.09.983. No abstract available.

35.

Canadian Cardiovascular Society/Canadian Heart Rhythm Society 2016 Implantable Cardioverter-Defibrillator Guidelines.

Bennett M, Parkash R, Nery P, Sénéchal M, Mondesert B, Birnie D, Sterns LD, Rinne C, Exner D, Philippon F, Campbell D, Cox J, Dorian P, Essebag V, Krahn A, Manlucu J, Molin F, Slawnych M, Talajic M.

Can J Cardiol. 2017 Feb;33(2):174-188. doi: 10.1016/j.cjca.2016.09.009. Epub 2016 Oct 6.

PMID:
28034580
36.

Electrophysiological abnormalities in subjects with lone atrial fibrillation - Too little, too late?

Nair GM, Nery PB, Redpath CJ, Sadek MM, Birnie DH.

Indian Pacing Electrophysiol J. 2016 Sep - Oct;16(5):149-151. doi: 10.1016/j.ipej.2016.11.012. Epub 2016 Nov 30. No abstract available.

37.

Role of 18F-Fluorodeoxyglucose/Positron Emission Tomography Imaging to Demonstrate Resolution of Acute Myocarditis.

Aleksova N, Juneau D, Dick A, Green M, Birnie D, Beanlands RS, Nery PB.

Can J Cardiol. 2017 Feb;33(2):293.e3-293.e5. doi: 10.1016/j.cjca.2016.08.011. Epub 2016 Aug 20.

PMID:
27923584
38.

Scar-based catheter ablation for persistent atrial fibrillation.

Nery PB, Thornhill R, Nair GM, Pena E, Redpath CJ.

Curr Opin Cardiol. 2017 Jan;32(1):1-9. Review.

PMID:
27875475
39.

Efficacy of adjunctive measures used to assist pulmonary vein isolation for atrial fibrillation: a systematic review.

Nair GM, Raut R, Bami K, Nery PB, Redpath CJ, Sadek MM, Green MS, Birnie DH.

Curr Opin Cardiol. 2017 Jan;32(1):58-68. Review.

PMID:
27755138
40.

Canadian Registry of Implantable Electronic Device Outcomes: Surveillance of the Riata Lead Under Advisory.

Parkash R, Thibault B, Mangat I, Coutu B, Bennett M, Healey J, Verma A, Philippon F, Sandhu R, Cameron D, Ayala-Paredes F, Sterns L, Essebag V, Kus T, Nery P, Stephenson E, Yee R, Exner D, Toal S, Birnie D, Wells G, Krahn A.

Circ Arrhythm Electrophysiol. 2016 Oct;9(10). pii: e004282.

PMID:
27733493
41.

Identifying and Managing Premature Ventricular Contraction-Induced Cardiomyopathy: What, Why, and How?

Alqarawi WA, Ramirez FD, Nery PB, Redpath CJ, Sadek MM, Green MS, Birnie DH, Nair GM.

Can J Cardiol. 2017 Feb;33(2):287-290. doi: 10.1016/j.cjca.2016.06.010. Epub 2016 Jul 1.

PMID:
27707526
42.

Systemic and inflammatory disorders involving the heart: the role of PET imaging.

Juneau D, Erthal F, Alzahrani A, Alenazy A, Nery PB, Beanlands RS, Chow BJ.

Q J Nucl Med Mol Imaging. 2016 Dec;60(4):383-96. Epub 2016 Sep 9. Review.

43.

Effect of Applying Force to Self-Adhesive Electrodes on Transthoracic Impedance: Implications for Electrical Cardioversion.

Ramirez FD, Fiset SL, Cleland MJ, Zakutney TJ, Nery PB, Nair GM, Redpath CJ, Sadek MM, Birnie DH.

Pacing Clin Electrophysiol. 2016 Oct;39(10):1141-1147. doi: 10.1111/pace.12937. Epub 2016 Sep 22.

PMID:
27550777
44.

Relationship Between Pulmonary Vein Reconnection and Atrial Fibrillation Recurrence: A Systematic Review and Meta-Analysis.

Nery PB, Belliveau D, Nair GM, Bernick J, Redpath CJ, Szczotka A, Sadek MM, Green MS, Wells G, Birnie DH.

JACC Clin Electrophysiol. 2016 Aug;2(4):474-483. doi: 10.1016/j.jacep.2016.02.003. Epub 2016 Apr 6.

45.

Cardiac manifestations of sarcoidosis: diagnosis and management.

Birnie DH, Kandolin R, Nery PB, Kupari M.

Eur Heart J. 2017 Sep 14;38(35):2663-2670. doi: 10.1093/eurheartj/ehw328.

PMID:
27469375
46.

Cardiac Sarcoidosis.

Birnie DH, Nery PB, Ha AC, Beanlands RS.

J Am Coll Cardiol. 2016 Jul 26;68(4):411-21. doi: 10.1016/j.jacc.2016.03.605. Review.

47.

Imaging of cardiac sarcoidosis.

Erthal F, Juneau D, Lim SP, Dwivedi G, Nery PB, Birnie D, Beanlands RS.

Q J Nucl Med Mol Imaging. 2016 Sep;60(3):252-63. Epub 2016 May 26. Review.

48.

Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.

Sapp JL, Wells GA, Parkash R, Stevenson WG, Blier L, Sarrazin JF, Thibault B, Rivard L, Gula L, Leong-Sit P, Essebag V, Nery PB, Tung SK, Raymond JM, Sterns LD, Veenhuyzen GD, Healey JS, Redfearn D, Roux JF, Tang AS.

N Engl J Med. 2016 Jul 14;375(2):111-21. doi: 10.1056/NEJMoa1513614. Epub 2016 May 5.

49.

Strategy of continued vs interrupted novel oral anticoagulant at time of device surgery in patients with moderate to high risk of arterial thromboembolic events: The BRUISE CONTROL-2 trial.

Essebag V, Healey JS, Ayala-Paredes F, Kalfon E, Coutu B, Nery P, Verma A, Sapp J, Philippon F, Sandhu RK, Coyle D, Eikelboom J, Wells G, Birnie DH.

Am Heart J. 2016 Mar;173:102-7. doi: 10.1016/j.ahj.2015.12.007. Epub 2015 Dec 19.

PMID:
26920602
50.

Cardiac Sarcoidosis.

Birnie D, Ha AC, Gula LJ, Chakrabarti S, Beanlands RS, Nery P.

Clin Chest Med. 2015 Dec;36(4):657-68. doi: 10.1016/j.ccm.2015.08.008. Epub 2015 Sep 11. Review.

PMID:
26593140

Supplemental Content

Support Center